Show simple item record

dc.contributor.authorLucio, Jose 
dc.contributor.authorAlcazar-Fuoli, Laura 
dc.contributor.authorGil, Horacio 
dc.contributor.authorCano-Pascual, Samuel
dc.contributor.authorHernandez-Egido, Sara
dc.contributor.authorCuetara, Maria Soledad
dc.contributor.authorMellado, Emilia 
dc.date.accessioned2024-07-03T07:17:41Z
dc.date.available2024-07-03T07:17:41Z
dc.date.issued2024-04
dc.identifier.citationMycoses. 2024 Apr;67(4):e13719.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/19922
dc.description.abstractBackground: Surveillance studies are crucial for updating trends in Aspergillus species and antifungal susceptibility information. Objectives: Determine the Aspergillus species distribution and azole resistance prevalence during this 3-year prospective surveillance study in a Spanish hospital. Materials and methods: Three hundred thirty-five Aspergillus spp. clinical and environmental isolates were collected during a 3-year study. All isolates were screened for azole resistance using an agar-based screening method and resistance was confirmed by EUCAST antifungal susceptibility testing. The azole resistance mechanism was confirmed by sequencing the cyp51A gene and its promoter. All Aspergillus fumigatus strains were genotyped using TRESPERG analysis. Results: Aspergillus fumigatus was the predominant species recovered with a total of 174 strains (51.94%). The rest of Aspergillus spp. were less frequent: Aspergillus niger (14.93%), Aspergillus terreus (9.55%), Aspergillus flavus (8.36%), Aspergillus nidulans (5.37%) and Aspergillus lentulus (3.28%), among other Aspergillus species (6.57%). TRESPERG analysis showed 99 different genotypes, with 72.73% of the strains being represented as a single genotype. Some genotypes were common among clinical and environmental A. fumigatus azole-susceptible strains, even when isolated months apart. We describe the occurrence of two azole-resistant A. fumigatus strains, one clinical and another environmental, that were genotypically different and did not share genotypes with any of the azole-susceptible strains. Conclusions: Aspergillus fumigatus strains showed a very diverse population although several genotypes were shared among clinical and environmental strains. The isolation of azole-resistant strains from both settings suggest that an efficient analysis of clinical and environmental sources must be done to detect azole resistance in A. fumigatus.es_ES
dc.description.sponsorshipThis research was funded by Fondo de Investigación Sanitaria (FISPI21CIII/00028). J. Lucio held a predoctoral fellowship from the Fondo de Investigación Sanitaria (F17 CIII/00037). This research is also supported by the Center for Biomedical Research in Infectious Diseases (CIBERINFEC-CB21/13/00105), Instituto de Salud Carlos III (ISCIII), Majadahonda, Madrid, Spain.es_ES
dc.language.isoenges_ES
dc.publisherWiley es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAspergillus sppes_ES
dc.subjectAzole resistancees_ES
dc.subjectHospital environmentes_ES
dc.subjectSurveillancees_ES
dc.subjectTRESPERG genotypinges_ES
dc.subject.meshAspergillosis es_ES
dc.subject.meshAspergillus nidulans es_ES
dc.subject.meshHumans es_ES
dc.subject.meshAzoles es_ES
dc.subject.meshAntifungal Agents es_ES
dc.subject.meshPrevalence es_ES
dc.subject.meshProspective Studies es_ES
dc.subject.meshDrug Resistance, Fungal es_ES
dc.subject.meshAspergillus fumigatus es_ES
dc.subject.meshHospitals es_ES
dc.subject.meshFungal Proteins es_ES
dc.subject.meshMicrobial Sensitivity Tests es_ES
dc.titleDistribution of Aspergillus species and prevalence of azole resistance in clinical and environmental samples from a Spanish hospital during a three-year study periodes_ES
dc.typeresearch articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID38551063es_ES
dc.format.volume67es_ES
dc.format.number4es_ES
dc.format.pagee13719es_ES
dc.identifier.doi10.1111/myc.13719es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderCentro de Investigación Biomédica en Red - CIBERINFEC (Enfermedades Infecciosas) es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1439-0507es_ES
dc.relation.publisherversionhttps://doi.org/10.1111/myc.13719es_ES
dc.identifier.journalMycoseses_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III///PI21-ISCIII Modalidad Proyectos de Investigacion en Salud Intramurales. (2021)/PI21CIII/00028es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/F17CIII/00037es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/CB21/13/00105es_ES


Files in this item

Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional